🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Veggie Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

50 mcg (40% DV)
✅ Within RDA (0.4× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.05mg
DiosVein Diosmin EP
900 mg
Natural Orange extract
100 mg

Other Ingredients

Modified Cellulose Rice powder Glycerol Monostearate Magnesium Stearate Silicon Dioxide Ascorbyl Palmitate Rosemary extract

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested Adult Use: Take 2 capsules daily. For optimal absorption, take with a fat-containing meal, or as recommended by a nutritionally-informed physician.

⚠️ Warnings & Precautions

Warning: Contains vitamin K.

Consult your physician if using blood-thinning medications such as warfarin.

🧪 Formulation Notes

Doctor’s Best Vein Support contains DiosVein Diosmin, used for decades for vascular support in Europe. Derived from sweet orange and rich in bioflavonoids, DiosVein has been shown in clinical studies to support blood vessel health and support normal circulatory function.

Further studies have found that Diosmin in combination with the flavonoid hesperidin supports healthy venous function.

Vein Support also contains MenaQ7, a long-acting, natural form of Vitamin K2 purified from fermented chickpeas.

Adequate K2 is important for healthy blood vessel function and MenaQ7 is a long-acting form shown to support cardiovascular health.

Vein Support with DiosVein and MenaQ7 Vitamin K2 as MK-7

Vegan

Warning: Contains vitamin K.

Non-GMO Gluten free Soy free

Additional Information

Helps support blood vessel health Helps support normal circulatory function Helps support cardiovascular health

YDRB185-3

Helps support healthy circulation

Vegan

Store in a cool dry place.

Product Details

UPC / SKU 7 53950 00185 5
DSLD Entry Date 2019-05-28
Product Type Other Combinations
Form Capsule
DSLD ID 203095
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →